Trials / Completed
CompletedNCT03826615
Gabapentin Pretreatment for Staged Bilateral Cataract Operations
The Effect of Gabapentin Pretreatment on Hyperalgesia in Elderly Patients Undergoing Staged Bilateral Cataract Operations
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 64 (actual)
- Sponsor
- Seoul National University Hospital · Academic / Other
- Sex
- All
- Age
- 60 Years
- Healthy volunteers
- Not accepted
Summary
To evaluate the effect of oral gabapentin premedication on hyperalgesia in elderly patients undergoing staged bilateral cataract operations under monitored anesthesia care
Detailed description
It has been reported that patients with bilateral cataract complained more pain and discomfort during the second consecutive eye surgery compared to the first eye surgery. Gabapentin is an anticonvulsant drug, which has been extended the use to perioperative analgesia, and anxiolysis. Therefore, the investigators conducted this randomized, controlled study to evaluate the effects of gabapentin premedication on patients' subjective sensations, including intraoperative anxiety, perceptions of pain, and light sensitivity, in the second cataract operations.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Gabapentin | Patients receive gabapentin 100mg orally for 3 times a day during the period of first and second cataract operations |
Timeline
- Start date
- 2019-02-01
- Primary completion
- 2020-01-03
- Completion
- 2020-01-03
- First posted
- 2019-02-01
- Last updated
- 2020-11-12
Locations
1 site across 1 country: South Korea
Source: ClinicalTrials.gov record NCT03826615. Inclusion in this directory is not an endorsement.